These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3353876)

  • 1. Platelet size in patients with chronic airflow obstruction with and without hypoxaemia.
    Wedzicha JA; Cotter FE; Empey DW
    Thorax; 1988 Jan; 43(1):61-4. PubMed ID: 3353876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia.
    Wedzicha JA; Syndercombe-Court D; Tan KC
    Thorax; 1991 Jul; 46(7):504-7. PubMed ID: 1877038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of forced expiratory volume in 1 s in screening subjects with stable COPD for PaO2 < 7.3 kPa qualifying for long-term oxygen therapy.
    Lim S; MacRae KD; Seed WA; Roberts CM
    Respir Med; 1998 Sep; 92(9):1122-6. PubMed ID: 9926166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short term effect of oxygen on renal haemodynamics in patients with hypoxaemic chronic obstructive airways disease.
    Baudouin SV; Bott J; Ward A; Deane C; Moxham J
    Thorax; 1992 Jul; 47(7):550-4. PubMed ID: 1412101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of platelet survival time with oxygen in patients with chronic obstructive airway disease.
    Johnson TS; Ellis JH; Steele PP
    Am Rev Respir Dis; 1978 Feb; 117(2):255-7. PubMed ID: 637408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment.
    Bratel T; Wennlund A; Carlström K
    Respir Med; 2000 Dec; 94(12):1221-8. PubMed ID: 11192959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Critical study of the indications for long-term oxygen therapy. Chronic obstructive bronchopneumopathies].
    Sadoul P; Duwoos H; Pretet S
    Rev Mal Respir; 1988; 5(4):363-72. PubMed ID: 3140316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease.
    Stewart AG; Waterhouse JC; Howard P
    Eur Respir J; 1991 Nov; 4(10):1207-14. PubMed ID: 1804668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease.
    Koo KW; Sax DS; Snider GL
    Am J Med; 1975 May; 58(5):663-70. PubMed ID: 236652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen therapy titrated to raise mixed venous oxygen content in COPD.
    Peil ML; Rubin LJ
    Chest; 1986 Mar; 89(3):343-7. PubMed ID: 3948546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary response to oxygen therapy in hypoxaemic chronic airflow obstruction.
    Hunt JM; Copland J; McDonald CF; Barter CE; Rochford PD; Pierce RJ
    Thorax; 1989 Nov; 44(11):930-6. PubMed ID: 2595634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal hypoxaemia in chronic obstructive pulmonary disease.
    Stradling JR; Lane DJ
    Clin Sci (Lond); 1983 Feb; 64(2):213-22. PubMed ID: 6681599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new nasal oxygen mask.
    Harvey JE; Schlecht BJ; Grant LJ; Tottle CR; Tanser AR
    Br J Dis Chest; 1983 Oct; 77(4):376-80. PubMed ID: 6639864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy.
    Skwarski K; MacNee W; Wraith PK; Sliwinski P; Zielinski J
    Chest; 1991 Dec; 100(6):1522-7. PubMed ID: 1959390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aminophylline on brain tissue oxygenation in patients with chronic obstructive lung disease.
    Nishimura M; Suzuki A; Yoshioka A; Yamamoto M; Akiyama Y; Miyamoto K; Kishi F; Kawakami Y
    Thorax; 1992 Dec; 47(12):1025-9. PubMed ID: 1494765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for nocturnal hypoxaemia (mean SaO2 < 90%) in normoxic and mildly hypoxic patients with COPD.
    Vos PJ; Folgering HT; van Herwaarden CL
    Eur Respir J; 1995 Jan; 8(1):74-7. PubMed ID: 7744197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conservation device for oxygen therapy in COPD.
    Evans TW; Waterhouse JC; Suggett AJ; Howard P
    Eur Respir J; 1988 Dec; 1(10):959-61. PubMed ID: 3147198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease.
    Goldstein RS; Ramcharan V; Bowes G; McNicholas WT; Bradley D; Phillipson EA
    N Engl J Med; 1984 Feb; 310(7):425-9. PubMed ID: 6420700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg.
    Fletcher EC; Luckett RA; Goodnight-White S; Miller CC; Qian W; Costarangos-Galarza C
    Am Rev Respir Dis; 1992 May; 145(5):1070-6. PubMed ID: 1586049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD).
    Vos PJ; Folgering HT; de Boo TM; Lemmens WJ; van Herwaarden CL
    Eur Respir J; 1994 May; 7(5):850-5. PubMed ID: 7519567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.